-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
In a recent video interview with Applied Clinical Trials, Derek Ansel, vice president, therapeutic strategy lead, rare disease, Worldwide Clinical Trials, discussed the unique challenges in rare disease R&D, including competing priorities among researchers, difficulty in diagnosing and treating patients, and defining endpoints due to varying symptoms.
-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
Johnson & Johnson has shared positive data from a subgroup analysis of the Phase III ICONIC-LEAD clinical trial of its investigational icotrokinra for the treatment of moderate-to-severe plaque psoriasis.
-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
April 15, 2025By In this video interview, Derek Ansel, vice president, therapeutic strategy lead, rare disease, Worldwide Clinical Trials, talks collaboration and maximizing resources among the various stakeholders in rare disease research.
-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
In a recent video interview with Applied Clinical Trials, Derek Ansel, vice president, therapeutic strategy lead, rare disease, Worldwide Clinical Trials, discussed the unique challenges in rare disease R&D, including competing priorities among researchers, difficulty in diagnosing and treating patients, and defining endpoints due to varying symptoms.
-
2 weeks ago | 
appliedclinicaltrialsonline.com | Andy Studna
April 11, 2025By In this video interview, Thierry Escudier, portfolio lead, Pistoia Alliance, highlights the need for maintaining data privacy in a highly regulated clinical research industry. In a recent video interview with Applied Clinical Trials, Theirry Escudier, Portfolio Lead, Pistoia Alliance, discussed the alliance’s newest initiative to assess the carbon footprint of clinical trials.
-
2 weeks ago | 
appliedclinicaltrialsonline.com | Andy Studna
April 10, 2025By In this video interview, Thierry Escudier, portfolio lead, Pistoia Alliance, discusses how an emphasis on patient centricity can encourage more sustainable trial designs. In a recent video interview with Applied Clinical Trials, Theirry Escudier, Portfolio Lead, Pistoia Alliance, discussed the alliance’s newest initiative to assess the carbon footprint of clinical trials.
-
2 weeks ago | 
appliedclinicaltrialsonline.com | Andy Studna
April 9, 2025By In this video interview, Thierry Escudier, portfolio lead, Pistoia Alliance, talks the current landscape of sustainability in clinical trials and how stakeholders are beginning to pay more attention to carbon footprint amid increasing protocol complexity. In a recent video interview with Applied Clinical Trials, Theirry Escudier, Portfolio Lead, Pistoia Alliance, discussed the alliance’s newest initiative to assess the carbon footprint of clinical trials.
-
2 weeks ago | 
appliedclinicaltrialsonline.com | Andy Studna
April 8, 2025By In this video interview, Thierry Escudier, portfolio lead, Pistoia Alliance, highlights where regulatory agencies currently stand on sustainability in clinical trials and how pharma companies are looking to reduce their carbon footprint. In a recent video interview with Applied Clinical Trials, Theirry Escudier, Portfolio Lead, Pistoia Alliance, discussed the alliance’s newest initiative to assess the carbon footprint of clinical trials.
-
2 weeks ago | 
appliedclinicaltrialsonline.com | Andy Studna
Roche has announced results from the Phase III MUSETTE clinical trial of high-dose Ocrevus (ocrelizumab) intravenous (IV) infusion in patients with relapsing multiple sclerosis (RMS).
-
2 weeks ago | 
appliedclinicaltrialsonline.com | Andy Studna
April 7, 2025By In this video interview, Thierry Escudier, portfolio lead, Pistoia Alliance, discusses the alliance’s latest step in evaluating the sustainability of digital versus traditional clinical trial approaches. In a recent video interview with Applied Clinical Trials, Theirry Escudier, Portfolio Lead, Pistoia Alliance, discussed the alliance’s newest initiative to assess the carbon footprint of clinical trials.
